ticlopidine has been researched along with Dementia in 5 studies
Ticlopidine: An effective inhibitor of platelet aggregation commonly used in the placement of STENTS in CORONARY ARTERIES.
ticlopidine : A thienopyridine that is 4,5,6,7-tetrahydrothieno[3,2-c]pyridine in which the hydrogen attached to the nitrogen is replaced by an o-chlorobenzyl group.
Dementia: An acquired organic mental disorder with loss of intellectual abilities of sufficient severity to interfere with social or occupational functioning. The dysfunction is multifaceted and involves memory, behavior, personality, judgment, attention, spatial relations, language, abstract thought, and other executive functions. The intellectual decline is usually progressive, and initially spares the level of consciousness.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To investigate the impact of MHRA DHPCs on prescribing practice in the secondary-care setting, looking specifically at a drug-drug interaction-the concomitant use of clopidogrel and proton pump inhibitors (PPIs) [as omeprazole]-and a drug-disease contraindication-the use of conventional (typical) antipsychotics in dementia." | 3.79 | The impact of direct healthcare professional communication on prescribing practice in the UK hospital setting: an interrupted time series analysis. ( Coleman, JJ; Dhami, A; Hodson, J; McIlroy, G; Thomas, SK, 2013) |
| "Clopidogrel use after drug-eluting stent (DES) coronary artery implantation is essential for the prevention of early in-stent thrombosis, but clopidogrel use among older DES recipients has not been widely studied." | 3.78 | Clopidogrel use and early outcomes among older patients receiving a drug-eluting coronary artery stent. ( Malenka, DJ; Morden, NE; Roth, GA; Skinner, J; Zhou, W, 2012) |
| "Vascular dementia is a common and potentially reversible type of dementing illness." | 1.27 | Validation of cognitive and functional assessment instruments in vascular dementia. ( Greenough, PG; Hershey, LA; Jaffe, DF; Yang, SL, 1987) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Thomas, SK | 1 |
| Hodson, J | 1 |
| McIlroy, G | 1 |
| Dhami, A | 1 |
| Coleman, JJ | 1 |
| Eusebi, LH | 1 |
| Rabitti, S | 1 |
| Artesiani, ML | 1 |
| Gelli, D | 1 |
| Montagnani, M | 1 |
| Zagari, RM | 1 |
| Bazzoli, F | 1 |
| Roth, GA | 1 |
| Morden, NE | 1 |
| Zhou, W | 1 |
| Malenka, DJ | 1 |
| Skinner, J | 1 |
| Trabucchi, M | 1 |
| Bianchetti, A | 1 |
| Hershey, LA | 1 |
| Jaffe, DF | 1 |
| Greenough, PG | 1 |
| Yang, SL | 1 |
2 reviews available for ticlopidine and Dementia
| Article | Year |
|---|---|
Proton pump inhibitors: Risks of long-term use.
Topics: Calcium; Cardiovascular Diseases; Clopidogrel; Dementia; Drug Interactions; Fractures, Bone; Gastroi | 2017 |
[Guidelines for the treatment of dementias].
Topics: Alzheimer Disease; Cholinesterase Inhibitors; Dementia; Dementia, Vascular; Diagnosis, Differential; | 2000 |
3 other studies available for ticlopidine and Dementia
| Article | Year |
|---|---|
The impact of direct healthcare professional communication on prescribing practice in the UK hospital setting: an interrupted time series analysis.
Topics: Adverse Drug Reaction Reporting Systems; Antipsychotic Agents; Clopidogrel; Communication; Dementia; | 2013 |
Clopidogrel use and early outcomes among older patients receiving a drug-eluting coronary artery stent.
Topics: Age Factors; Aged; Aged, 80 and over; Blood Vessel Prosthesis Implantation; Clopidogrel; Coronary Ar | 2012 |
Validation of cognitive and functional assessment instruments in vascular dementia.
Topics: Aged; Aged, 80 and over; Aspirin; Brain Ischemia; Dementia; Double-Blind Method; Female; Humans; Mal | 1987 |